Congenital myasthenia syndrome due to CHRNA1 mutation resulting in respiratory failure
DOI:
https://doi.org/10.18203/2349-3291.ijcp20250104Keywords:
CMS, Neuromuscular junction, Muscle weaknessAbstract
CMS is an inherited disorder, characterized by defective transmission at Neuromuscular Junction affecting from birth or soon after. It results in fatigue and muscle weakness because of genetic abnormalities that interfere with the neuromuscular junction's ability to function. The most typical signs of CMS include eyelid drooping, breathing difficulties, muscle weakness and weariness with variations depending on specific genetic mutations. Clinical examinations, neurophysiologic tests, and genetic analyses are frequently combined to make the diagnosis of CMS. Although there is no known treatment for CMS, many patients may control their symptoms and lead relatively normal lives with the right care. A newborn with CMS due to CHRNA1 gene mutation is described in this article, along with its very early onset. The CHRNA1 mutation is a rare variant in the Indian population. Due to muscle weakness, the neonate in this case developed severe respiratory distress and later succumbed to death despite rigorous life-saving measures.
Metrics
References
Farjami Z, Khodaenia N, Ebrahimi N, Zamani G, Ashnaei AH, Galehdari M, et al. A case report of congenital myasthenic syndrome caused by a mutation in theCHRNE genein the Iranian population. Iran J Child Neurol. 2020;14(4):87-94.
Mendpara V, Bethanabotla S, Yadav M, Kanisetti V, Singh G, Das A, et al. When breathing becomes a challenge: a case of congenital myasthenia gravis in an indian neonate with a DOK-7 gene mutation. Cureus. 2023s;15(5):38842. DOI: https://doi.org/10.7759/cureus.38842
Shen Y, Wang B, Zheng X, Zhang W, Wu H, Hei M. A neonate with musk congenital myasthenic syndrome presenting with refractory respiratory failure. Frontiers in ped. 2020;8:166. DOI: https://doi.org/10.3389/fped.2020.00166
Lorenzoni PJ, Scola RH, Kay CS, Werneck LC. Congenital myasthenic syndrome: a brief review. Pediatric Neurol. 2012;46(3):141-8. DOI: https://doi.org/10.1016/j.pediatrneurol.2011.12.001
Adams GT, Snieder H, McKie V. Bibliography Current World Literature. Current Opinion in Pediatrics. 2003;15:650-86 DOI: https://doi.org/10.1097/00008480-200312000-00018
Hantaï D, Richard P, Koenig J, Eymard B. Congenital myasthenic syndromes. Current Ppin Neurol. 2004;17(5):539-51. DOI: https://doi.org/10.1097/00019052-200410000-00004
Kaplan, Claude J. The 2016 version of the gene table of monogenic neuromuscular disorders (nuclear genome). Neuromuscular Dis. 2016;25(12):991-1020. DOI: https://doi.org/10.1016/j.nmd.2015.10.010
Joshi RM, Bharucha BA, Mohire MD, Kumta NB. Congenital myasthenia gravis (a case report). J Postgrad Med. 1985;31:109–11.
Shervin Badv R, Memarian S, Ghahvechi M. A case report of congenital myasthenia gravis presenting with respiratory distress. Casp J Neurol Sci. 2018;4:35–8. DOI: https://doi.org/10.29252/nirp.cjns.4.12.35
Engel AG, Shen XM, Selcen D, Sine SM. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. The Lancet Neurology. 2015;14(4):420-34. DOI: https://doi.org/10.1016/S1474-4422(14)70201-7
Chevessier F, Faraut B, Ravel-Chapuis A, Richard P, Gaudon K, Bauche S, et al. MUSK, a new target for mutations causing congenital myasthenic syndrome. Human molecular genetics. 2004;13(24):3229-40. DOI: https://doi.org/10.1093/hmg/ddh333